The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Escitalopram Oxalate API Market Research Report 2025
Synopsis
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
The global Escitalopram Oxalate API market was valued at US$ 64 million in 2023 and is anticipated to reach US$ 103.4 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
This report aims to provide a comprehensive presentation of the global market for Escitalopram Oxalate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Escitalopram Oxalate API.
Report Scope
The Escitalopram Oxalate API market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Escitalopram Oxalate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Escitalopram Oxalate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Segment by Application
Depression Drug
Anxiety Drug
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Escitalopram Oxalate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Escitalopram Oxalate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Escitalopram is used to treat depression and anxiety. It works by helping to restore the balance of a certain natural substance (serotonin) in the brain. The mechanism of antidepressant action of escitalopram, the S-enantiomer of racemic citalopram, is presumed to be linked to potentiation of serotonergic activity in the central nervous system (CNS) resulting from its inhibition of CNS neuronal reuptake of serotonin (5-HT).
Escitalopram oxalate is an active pharmaceutical ingredient (API) used in the manufacturing of antidepressant medications. Escitalopram oxalate API is a fine white to off-white crystalline powder, which is soluble in water and typically used in tablet form.
The global Escitalopram Oxalate API market was valued at US$ 64 million in 2023 and is anticipated to reach US$ 103.4 million by 2030, witnessing a CAGR of 6.9% during the forecast period 2024-2030.
Global key players of Escitalopram Oxalate API include Zhejiang Huahai, Dr. Reddy's, Shodhana Laboratories, Viatris, Aurobindo, etc. The top five players hold a share over 55%. Asia Pacific dominates the global Escitalopram Oxalate API market, with a share over 50% of the sales in value. In addition, Europe is also an important sales region. In terms of product type, both USDMF and COS/E-DMF is the largest segment, with a share about 90%. In terms of product application, the largest application is depression drug, with a share about 77%, followed by anxiety drug.
This report aims to provide a comprehensive presentation of the global market for Escitalopram Oxalate API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Escitalopram Oxalate API.
Report Scope
The Escitalopram Oxalate API market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Escitalopram Oxalate API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Escitalopram Oxalate API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sichuan Kelun
Zhejiang Huahai
Haisen Pharma
Viatris
Cipla
Aurobindo
Hetero Labs
Neuland
Smilax Laboratories
Jubilant Generics
Cadila Pharmaceuticals
Natco Pharma
Shodhana Laboratories
Dr. Reddy's
Segment by Type
Both USDMF and COS/E-DM
Only USDMF or COS/E-DM
Segment by Application
Depression Drug
Anxiety Drug
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Escitalopram Oxalate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Escitalopram Oxalate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Escitalopram Oxalate API Market Overview
1.1 Product Overview and Scope of Escitalopram Oxalate API
1.2 Escitalopram Oxalate API Segment by Type
1.2.1 Global Escitalopram Oxalate API Market Value Comparison by Type (2024-2030)
1.2.2 Both USDMF and COS/E-DM
1.2.3 Only USDMF or COS/E-DM
1.3 Escitalopram Oxalate API Segment by Application
1.3.1 Global Escitalopram Oxalate API Market Value by Application: (2024-2030)
1.3.2 Depression Drug
1.3.3 Anxiety Drug
1.4 Global Escitalopram Oxalate API Market Size Estimates and Forecasts
1.4.1 Global Escitalopram Oxalate API Revenue 2019-2030
1.4.2 Global Escitalopram Oxalate API Sales 2019-2030
1.4.3 Global Escitalopram Oxalate API Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Escitalopram Oxalate API Market Competition by Manufacturers
2.1 Global Escitalopram Oxalate API Sales Market Share by Manufacturers (2019-2024)
2.2 Global Escitalopram Oxalate API Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Escitalopram Oxalate API Average Price by Manufacturers (2019-2024)
2.4 Global Escitalopram Oxalate API Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Escitalopram Oxalate API, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Escitalopram Oxalate API, Product Type & Application
2.7 Escitalopram Oxalate API Market Competitive Situation and Trends
2.7.1 Escitalopram Oxalate API Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Escitalopram Oxalate API Players Market Share by Revenue
2.7.3 Global Escitalopram Oxalate API Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Escitalopram Oxalate API Retrospective Market Scenario by Region
3.1 Global Escitalopram Oxalate API Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Escitalopram Oxalate API Global Escitalopram Oxalate API Sales by Region: 2019-2030
3.2.1 Global Escitalopram Oxalate API Sales by Region: 2019-2024
3.2.2 Global Escitalopram Oxalate API Sales by Region: 2025-2030
3.3 Global Escitalopram Oxalate API Global Escitalopram Oxalate API Revenue by Region: 2019-2030
3.3.1 Global Escitalopram Oxalate API Revenue by Region: 2019-2024
3.3.2 Global Escitalopram Oxalate API Revenue by Region: 2025-2030
3.4 North America Escitalopram Oxalate API Market Facts & Figures by Country
3.4.1 North America Escitalopram Oxalate API Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Escitalopram Oxalate API Sales by Country (2019-2030)
3.4.3 North America Escitalopram Oxalate API Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Escitalopram Oxalate API Market Facts & Figures by Country
3.5.1 Europe Escitalopram Oxalate API Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Escitalopram Oxalate API Sales by Country (2019-2030)
3.5.3 Europe Escitalopram Oxalate API Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Escitalopram Oxalate API Market Facts & Figures by Country
3.6.1 Asia Pacific Escitalopram Oxalate API Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Escitalopram Oxalate API Sales by Country (2019-2030)
3.6.3 Asia Pacific Escitalopram Oxalate API Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Escitalopram Oxalate API Market Facts & Figures by Country
3.7.1 Latin America Escitalopram Oxalate API Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Escitalopram Oxalate API Sales by Country (2019-2030)
3.7.3 Latin America Escitalopram Oxalate API Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Escitalopram Oxalate API Market Facts & Figures by Country
3.8.1 Middle East and Africa Escitalopram Oxalate API Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Escitalopram Oxalate API Sales by Country (2019-2030)
3.8.3 Middle East and Africa Escitalopram Oxalate API Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Escitalopram Oxalate API Sales by Type (2019-2030)
4.1.1 Global Escitalopram Oxalate API Sales by Type (2019-2024)
4.1.2 Global Escitalopram Oxalate API Sales by Type (2025-2030)
4.1.3 Global Escitalopram Oxalate API Sales Market Share by Type (2019-2030)
4.2 Global Escitalopram Oxalate API Revenue by Type (2019-2030)
4.2.1 Global Escitalopram Oxalate API Revenue by Type (2019-2024)
4.2.2 Global Escitalopram Oxalate API Revenue by Type (2025-2030)
4.2.3 Global Escitalopram Oxalate API Revenue Market Share by Type (2019-2030)
4.3 Global Escitalopram Oxalate API Price by Type (2019-2030)
5 Segment by Application
5.1 Global Escitalopram Oxalate API Sales by Application (2019-2030)
5.1.1 Global Escitalopram Oxalate API Sales by Application (2019-2024)
5.1.2 Global Escitalopram Oxalate API Sales by Application (2025-2030)
5.1.3 Global Escitalopram Oxalate API Sales Market Share by Application (2019-2030)
5.2 Global Escitalopram Oxalate API Revenue by Application (2019-2030)
5.2.1 Global Escitalopram Oxalate API Revenue by Application (2019-2024)
5.2.2 Global Escitalopram Oxalate API Revenue by Application (2025-2030)
5.2.3 Global Escitalopram Oxalate API Revenue Market Share by Application (2019-2030)
5.3 Global Escitalopram Oxalate API Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sichuan Kelun
6.1.1 Sichuan Kelun Corporation Information
6.1.2 Sichuan Kelun Description and Business Overview
6.1.3 Sichuan Kelun Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sichuan Kelun Escitalopram Oxalate API Product Portfolio
6.1.5 Sichuan Kelun Recent Developments/Updates
6.2 Zhejiang Huahai
6.2.1 Zhejiang Huahai Corporation Information
6.2.2 Zhejiang Huahai Description and Business Overview
6.2.3 Zhejiang Huahai Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Zhejiang Huahai Escitalopram Oxalate API Product Portfolio
6.2.5 Zhejiang Huahai Recent Developments/Updates
6.3 Haisen Pharma
6.3.1 Haisen Pharma Corporation Information
6.3.2 Haisen Pharma Description and Business Overview
6.3.3 Haisen Pharma Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Haisen Pharma Escitalopram Oxalate API Product Portfolio
6.3.5 Haisen Pharma Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Escitalopram Oxalate API Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 Cipla
6.5.1 Cipla Corporation Information
6.5.2 Cipla Description and Business Overview
6.5.3 Cipla Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Cipla Escitalopram Oxalate API Product Portfolio
6.5.5 Cipla Recent Developments/Updates
6.6 Aurobindo
6.6.1 Aurobindo Corporation Information
6.6.2 Aurobindo Description and Business Overview
6.6.3 Aurobindo Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Aurobindo Escitalopram Oxalate API Product Portfolio
6.6.5 Aurobindo Recent Developments/Updates
6.7 Hetero Labs
6.6.1 Hetero Labs Corporation Information
6.6.2 Hetero Labs Description and Business Overview
6.6.3 Hetero Labs Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hetero Labs Escitalopram Oxalate API Product Portfolio
6.7.5 Hetero Labs Recent Developments/Updates
6.8 Neuland
6.8.1 Neuland Corporation Information
6.8.2 Neuland Description and Business Overview
6.8.3 Neuland Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Neuland Escitalopram Oxalate API Product Portfolio
6.8.5 Neuland Recent Developments/Updates
6.9 Smilax Laboratories
6.9.1 Smilax Laboratories Corporation Information
6.9.2 Smilax Laboratories Description and Business Overview
6.9.3 Smilax Laboratories Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Smilax Laboratories Escitalopram Oxalate API Product Portfolio
6.9.5 Smilax Laboratories Recent Developments/Updates
6.10 Jubilant Generics
6.10.1 Jubilant Generics Corporation Information
6.10.2 Jubilant Generics Description and Business Overview
6.10.3 Jubilant Generics Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jubilant Generics Escitalopram Oxalate API Product Portfolio
6.10.5 Jubilant Generics Recent Developments/Updates
6.11 Cadila Pharmaceuticals
6.11.1 Cadila Pharmaceuticals Corporation Information
6.11.2 Cadila Pharmaceuticals Escitalopram Oxalate API Description and Business Overview
6.11.3 Cadila Pharmaceuticals Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Cadila Pharmaceuticals Escitalopram Oxalate API Product Portfolio
6.11.5 Cadila Pharmaceuticals Recent Developments/Updates
6.12 Natco Pharma
6.12.1 Natco Pharma Corporation Information
6.12.2 Natco Pharma Escitalopram Oxalate API Description and Business Overview
6.12.3 Natco Pharma Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Natco Pharma Escitalopram Oxalate API Product Portfolio
6.12.5 Natco Pharma Recent Developments/Updates
6.13 Shodhana Laboratories
6.13.1 Shodhana Laboratories Corporation Information
6.13.2 Shodhana Laboratories Escitalopram Oxalate API Description and Business Overview
6.13.3 Shodhana Laboratories Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Shodhana Laboratories Escitalopram Oxalate API Product Portfolio
6.13.5 Shodhana Laboratories Recent Developments/Updates
6.14 Dr. Reddy's
6.14.1 Dr. Reddy's Corporation Information
6.14.2 Dr. Reddy's Escitalopram Oxalate API Description and Business Overview
6.14.3 Dr. Reddy's Escitalopram Oxalate API Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Dr. Reddy's Escitalopram Oxalate API Product Portfolio
6.14.5 Dr. Reddy's Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Escitalopram Oxalate API Industry Chain Analysis
7.2 Escitalopram Oxalate API Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Escitalopram Oxalate API Production Mode & Process
7.4 Escitalopram Oxalate API Sales and Marketing
7.4.1 Escitalopram Oxalate API Sales Channels
7.4.2 Escitalopram Oxalate API Distributors
7.5 Escitalopram Oxalate API Customers
8 Escitalopram Oxalate API Market Dynamics
8.1 Escitalopram Oxalate API Industry Trends
8.2 Escitalopram Oxalate API Market Drivers
8.3 Escitalopram Oxalate API Market Challenges
8.4 Escitalopram Oxalate API Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
